Initial Outcome After Selective Intraarterial Radionuclide Therapy with Yttrium-90 Microspheres as Salvage Therapy for Unresectable Metastatic Liver Disease

2013 ◽  
Vol 28 (7) ◽  
pp. 534-540 ◽  
Author(s):  
Cuneyt Turkmen ◽  
Adem Ucar ◽  
Arzu Poyanli ◽  
Betul Vatankulu ◽  
Gozde Ozkan ◽  
...  
Keyword(s):  
Liver Disease ◽  
Salvage Therapy ◽  
Radionuclide Therapy ◽  
Initial Outcome ◽  
Metastatic Liver ◽  
Yttrium 90

scholarly journals 04:03 PM Abstract No. 235 Pre-treatment FDG-PET can predict the survival after Yttrium-90 radio-embolization in metastatic liver disease

2019 ◽  
Vol 30 (3) ◽  
pp. S105-S106 ◽  
Author(s):  
S. Mehdizadeh Seraj ◽  
M. Zirakchian Zadeh ◽  
T. Werner ◽  
H. Zhuang ◽  
A. Alavi ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fdg Pet ◽  
Pre Treatment ◽  
Metastatic Liver ◽  
Yttrium 90

scholarly journals Interventional Oncology Approach to Hepatic Metastases

2020 ◽  
Vol 37 (05) ◽  
pp. 484-491
Author(s):  
Cathal O'Leary ◽  
Michael C. Soulen ◽  
Susan Shamimi-Noori
Keyword(s):  
Liver Disease ◽  
Liver Function ◽  
Interventional Oncology ◽  
Hepatic Metastases ◽  
Locoregional Therapy ◽  
Treatment Modalities ◽  
Patient Specific ◽  
Curative Intent ◽  
Locoregional Therapies ◽  
Metastatic Liver

AbstractMetastatic liver disease is one of the major causes of cancer-related morbidity and mortality. Locoregional therapies offered by interventional oncologists alleviate cancer-related morbidity and in some cases improve survival. Locoregional therapies are often palliative in nature but occasionally can be used with curative intent. This review will discuss important factors to consider prior to palliative and curative intent treatment of metastatic liver disease with locoregional therapy. These factors include those specific to the tumor, liver function, liver reserve, differences between treatment modalities, and patient-specific considerations.

274 Neoadjuvant treatment of metastatic liver disease with raltitrexed and oxaliplatin in colorectal cancer patients

2003 ◽  
Vol 1 (5) ◽  
pp. S84
Author(s):  
F.R. Garcia-Arroyo ◽  
J.M. Garcia-Bueno ◽  
M. Constenia ◽  
C. Vadell ◽  
P. Palacios ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Liver Disease ◽  
Cancer Patients ◽  
Neoadjuvant Treatment ◽  
Colorectal Cancer Patients ◽  
Metastatic Liver

scholarly journals Reproducibility and variability of very low dose hepatic perfusion CT in metastatic liver disease

2016 ◽  
Vol 22 (6) ◽  
pp. 495-500 ◽  
Author(s):  
Osman Melih Topcuoglu ◽  
Musturay Karcaaltincaba ◽  
Deniz Akata ◽  
Mustafa Nasuh Ozmen
Keyword(s):  
Liver Disease ◽  
Low Dose ◽  
Perfusion Ct ◽  
Hepatic Perfusion ◽  
Metastatic Liver

scholarly journals Risk-adapted strategy partial liver irradiation for the treatment of large volume metastatic liver disease

2013 ◽  
Vol 53 (5) ◽  
pp. 702-706 ◽  
Author(s):  
Katharine L. Aitken ◽  
Diana M. Tait ◽  
Christopher M. Nutting ◽  
Komel Khabra ◽  
Maria A. Hawkins
Keyword(s):  
Liver Disease ◽  
Large Volume ◽  
Metastatic Liver

scholarly journals Metastatic Liver Disease - Presenting as Multiple Hepatic Cysts

2015 ◽  
Vol 1 (1) ◽  
pp. 11-13
Author(s):  
John D. Goodwin ◽  
◽  
Jason Schmidt ◽  
Parvez Mantry ◽  
◽  
...  
Keyword(s):  
Liver Disease ◽  
Hepatic Cysts ◽  
Metastatic Liver

The Use of Thermography in the Detection of Metastatic Liver Disease

Radiology ◽  
1970 ◽  
Vol 95 (3) ◽  
pp. 696-698 ◽  
Author(s):  
Carl M. Mansfield ◽  
Corinne Farrell ◽  
Sucha O. Asbell
Keyword(s):  
Liver Disease ◽  
Metastatic Liver

scholarly journals Inflammation in Primary and Metastatic Liver Tumorigenesis–Under the Influence of Alcohol and High-Fat Diets

Nutrients ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 933 ◽  
Author(s):  
Lauren S. Strathearn ◽  
Afanasii I. Stepanov ◽  
Joan Font-Burgada
Keyword(s):  
Liver Disease ◽  
Liver Metastasis ◽  
Alcohol Intake ◽  
Cancer Type ◽  
High Fat ◽  
High Fat Diets ◽  
Excessive Alcohol ◽  
Fat Diets ◽  
Metastatic Liver ◽  
Excessive Alcohol Intake

The liver plays an outsized role in oncology. Liver tumors are one of the most frequently found tumors in cancer patients and these arise from either primary or metastatic disease. Hepatocellular carcinoma (HCC), the most prevalent form of primary liver cancer and the 6th most common cancer type overall, is expected to become the 3rd leading cause of cancer mortality in the US by the year 2030. The liver is also the most common site of distant metastasis from solid tumors. For instance, colorectal cancer (CRC) metastasizes to the liver in two-thirds of cases, and CRC liver metastasis is the leading cause of mortality in these patients. The interplay between inflammation and cancer is unmistakably evident in the liver. In nearly every case, HCC is diagnosed in chronic liver disease (CLD) and cirrhosis background. The consumption of a Western-style high-fat diet is a major risk factor for the development of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), both of which are becoming more prevalent in parallel with the obesity epidemic. Excessive alcohol intake also contributes significantly to the CLD burden in the form of alcoholic liver disease (ALD). Inflammation is a key component in the development of all CLDs. Additionally, during the development of liver metastasis, pro-inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro-metastatic environment that supports metastatic seeding and colonization. Here we review how Westernized high-fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment, stimulating both primary and metastatic liver tumorigenesis.

Sign in / Sign up

Export Citation Format

Share Document